Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Methods Mol Biol. 2020;2133:327-341. doi: 10.1007/978-1-0716-0434-2_16.
Cyclotides are naturally occurring microproteins (≈30 residues long) present in several families of plants. All cyclotides share a unique head-to-tail circular knotted topology containing three disulfide bridges forming a cystine knot topology. Cyclotides possess high stability to chemical, physical, and biological degradation and have been reported to cross cellular membranes. In addition, naturally occurring and engineered cyclotides have shown to possess various pharmacologically relevant activities. These unique features make the cyclotide scaffold an excellent tool for the design of novel peptide-based therapeutics by using molecular evolution and/or peptide epitope grafting techniques. In this chapter, we provide protocols to recombinantly produce a natively folded cyclotide making use of a standard bacterial expression system in combination with an intein-mediated backbone cyclization with concomitant oxidative folding.
环肽是天然存在的微蛋白(约 30 个残基长),存在于几种植物科中。所有环肽都具有独特的首尾环化拓扑结构,包含三个二硫键形成半胱氨酸结拓扑结构。环肽对化学、物理和生物降解具有很高的稳定性,并已被报道能够穿过细胞膜。此外,天然存在和工程化的环肽已被证明具有各种具有药理学相关性的活性。这些独特的特征使环肽支架成为通过使用分子进化和/或肽表位嫁接技术设计新型基于肽的治疗剂的极好工具。在本章中,我们提供了使用标准细菌表达系统结合内含子介导的骨架环化以及伴随的氧化折叠来重组生产天然折叠环肽的方案。